Identification of immune-based prostate cancer subtypes using mRNA expression

Area of Science:

• Oncology
• Immunology
• Bioinformatics

Background:

• Immune infiltration significantly impacts prostate cancer (PCa) clinical outcomes.
• Previous studies lacked detailed understanding of diverse immune cell contributions to PCa's immune response.
• Characterizing the tumor immune environment is crucial for effective PCa treatment strategies.

Purpose of the Study:

• To comprehensively analyze immune cell profiling in PCa.
• To identify molecular subtypes of PCa based on immune characteristics.
• To predict response to immunotherapy and identify potential therapeutic targets.

Main Methods:

• Utilized CIBERSORT for immune cell proportion analysis in PCa, adjacent, and normal samples.
• Employed R's 'CancerSubtypes' package for molecular classification and functional enrichment analysis.
• Applied Submap and Tumor Immune Dysfunction and Exclusion (TIDE) algorithms for immunotherapy response prediction and screened the Genomics of Drug Sensitivity in Cancer (GDSC) database for drug targets.

Main Results:

• Identified three distinct molecular subtypes within PCa tumors, each with unique molecular and clinical features.
• Cluster I was associated with advanced PCa and showed a higher likelihood of responding to immunotherapy.
• Functional enrichment analysis revealed subtype-specific characteristics influencing treatment response.

Conclusions:

• Immune response variations are key drivers of PCa progression and treatment outcomes.
• Comprehensive assessment of 22 immune cell types in the PCa Tumor Environment (TEM) provides critical insights into immunotherapy mechanisms.
• Findings support the development of novel therapeutic strategies and drug discovery for PCa.